SGMO -17% on something from 3Q18 PR/CC—probably ASH-related: https://finance.yahoo.com/news/sangamo-therapeutics-reports-third-quarter-210100146.html https://finance.yahoo.com/news/edited-transcript-sgmo-earnings-conference-043635478.html